SB-Bisop 5 mg (Tablet)
Unit Price: ৳ 10.00 (30's pack: ৳ 300.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Bisoprolol hemifumarate |
| Company | Sunman birdem pharma ltd |
Title
- SB-Bisop 5 mg Tablet
Categories
- Medicine
- Beta blocker
- Hypertension medication
- Heart medication
Description
- SB-Bisop 5 mg Tablet is a beta-blocker medication used to lower blood pressure, reduce the workload on the heart, and prevent chest pain. It is indicated for hypertension, angina, and moderate to severe heart failure. The pharmacology of Bisoprolol Hemifumarate, the active ingredient, includes selective ß1 adrenergic receptor blocking action in the heart and vascular smooth muscle, leading to a reduction in heart rate and cardiac output. The medicine has specific dosage and administration guidelines for adults, children, patients with renal or hepatic impairment, and the elderly. It interacts with other medications and has contraindications in specific medical conditions such as cardiogenic shock and heart failure. Side effects may include fatigue, dizziness, headache, gastrointestinal disturbances, cold or numb extremities, muscle weakness, and breathing difficulties. Precautions include using caution in adjusting the dose for patients with impaired renal or hepatic function and increased reactivity to allergens in patients with a history of severe anaphylactic reaction. The therapeutic class includes anti-adrenergic agents (Beta blockers). The chemical structure of Bisoprolol Hemifumarate is described by its molecular formula and structure. It has specific storage conditions and considerations for use during pregnancy and lactation.
Dimensions
- 5 mg Tablet
Color options
- Not applicable
Functions
- Lowers blood pressure
- Reduces workload on the heart
- Prevents chest pain
- Blocks ß1 adrenergic receptors
- Reduces heart rate and cardiac output
Materials
- Bisoprolol Hemifumarate
Technical specifications
- Selective ß1 adrenergic receptor blocker
- Absorption rate >90%
- Absolute bioavailability of 88%
- Metabolized via oxidative pathways
- Renally eliminated metabolites
- Major metabolic pathways involve CYPSA4 and CYP2D6
- Clearance balanced between renal elimination and hepatic metabolism
- Elimination half-life of 10-12 hours
Design elements
- Chemical structure depicted
Usability features
- Individualized dosage for mild to moderate hypertension
- Single daily dose
- Usable with or without food
- Best practice to take at the same time each day
Dosage forms
- Tablet
Age group
- Adults
- Children
- Geriatrics
Gender
- Not applicable
Power source
- Not applicable
Safety features
- Monitoring needed in patients with hepatic impairment or renal dysfunction
- Limited dialysability
- Increased reactivity to allergens
- Caution with a history of severe anaphylactic reaction
Additional accessories
- Not applicable
Care instructions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Warranty
- Not applicable
Assembly required
- Not applicable
Awards
- Not applicable